What are the types of Diabetes Mellitus (DM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

There are four main types of diabetes: Type 1 diabetes, Type 2 diabetes, Gestational diabetes mellitus, and Other specific types of diabetes. These categories are based on the underlying causes of the disease, such as autoimmune destruction of pancreatic beta cells in Type 1 diabetes, insulin resistance and impaired insulin secretion in Type 2 diabetes, and high blood sugar levels during pregnancy in Gestational diabetes mellitus 1. The classification of diabetes is crucial for determining the appropriate treatment approach, as different types of diabetes require different management strategies, such as insulin therapy, oral medications, lifestyle modifications, or a combination of these strategies.

Some key characteristics of each type of diabetes include:

  • Type 1 diabetes: typically develops in childhood or adolescence, results from autoimmune destruction of pancreatic beta cells, and requires lifelong insulin therapy 1
  • Type 2 diabetes: the most common form, often develops in adulthood, and is related to lifestyle factors like obesity and physical inactivity 1
  • Gestational diabetes mellitus: develops during pregnancy, usually resolves after childbirth, but increases the risk of developing Type 2 diabetes later 1
  • Other specific types of diabetes: include monogenic diabetes syndromes, diseases of the exocrine pancreas, and drug- or chemical-induced diabetes 2

Understanding the specific type of diabetes is essential for providing personalized care and improving patient outcomes, as different types of diabetes have distinct pathophysiologies and require tailored treatment approaches 1.

From the FDA Drug Label

The text does not explicitly mention the number of types of diabetes, but it does mention Type 1 Diabetes and Type 2 Diabetes. The FDA drug label mentions two types of diabetes:

  • Type 1 Diabetes
  • Type 2 Diabetes 3 4

From the Research

Types of Diabetes

There are several types of diabetes, including:

  • Type 1 diabetes mellitus
  • Type 2 diabetes mellitus
  • Gestational diabetes mellitus (GDM)
  • MODY 2 (a form of GDM caused by a glucokinase gene mutation) 5

Characteristics of Each Type

  • Type 1 diabetes mellitus: characterized by a failure in insulin production 6
  • Type 2 diabetes mellitus: characterized by a decrease in insulin sensitivity and function 6
  • Gestational diabetes mellitus (GDM): develops during pregnancy, typically in the second or third trimester 7, 8, 9, 5
  • MODY 2: a rare form of GDM caused by a genetic mutation, accounting for 1-2% of GDM cases 5

Prevalence and Management

  • The prevalence of diabetes is increasing globally, with type 1 and type 2 diabetes being the most common forms 6
  • Gestational diabetes mellitus (GDM) is diagnosed in approximately 5.5% of all births in Germany 5
  • Management of diabetes typically involves lifestyle modifications, insulin therapy, and/or oral hypoglycemic agents 7, 8, 9, 6

Related Questions

For a 114‑kg pregnant woman with type 2 diabetes who was taking insulin glargine (Lantus) 15 U daily and 5 U rapid‑acting insulin with meals before pregnancy, now at 28 weeks gestation, what should her insulin glargine dose, insulin‑sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) be?
In a 25‑year‑old woman who is 28 weeks pregnant, weighs 114 kg, currently using Lantus (insulin glargine) 40 U daily, an insulin‑to‑carbohydrate ratio of 1 U per 3 g carbohydrate, and an insulin sensitivity factor of 20 mg/dL per unit, with a dinner of 42 g carbohydrate resulting in a 1‑hour post‑prandial glucose of 114 mg/dL, a 2‑am glucose of 145 mg/dL corrected with 2 U of Novolog (insulin aspart), and a 6‑am fasting glucose of 157 mg/dL, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
For a 25‑year‑old woman at 28 weeks gestation with type 2 diabetes, weight 114 kg, on insulin glargine (Lantus) 32 U daily, insulin‑to‑carbohydrate ratio 1 U:5 g, and insulin sensitivity factor 1 U:25 mg/dL, who ate 55 g carbohydrate at 6 pm and had blood glucose 183 mg/dL at 9 pm and fasting glucose 187 mg/dL, how should her insulin sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted?
A 28‑week‑gestation pregnant woman weighing 114 kg has a fasting blood glucose of 157 mg/dL while on insulin glargine (Lantus) 40 units daily; how much should the insulin glargine dose be increased?
For a 114 kg pregnant woman with diabetes, what is the appropriate starting dose of insulin glargine (Lantus) and how should the basal dose be titrated, including total daily insulin requirement, insulin‑to‑carbohydrate ratio, and correction factor?
When to administer Deoxyribonuclease (DNase) and when to withhold it in a 5-year-old male child?
When to administer Dextrose Normal Saline (DNS) in a 5-year-old male child with loss of consciousness due to Road Traffic Accident (RTA)?
Who performs a dual-energy X-ray absorptiometry (DEXA) scan to assess body composition?
What is the relationship between Parathyroid Hormone (PTH), phosphate levels, and Procalcitonin (PCT)?
Can Angiotensin-Converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor Blockers (ARB) be used after revascularization of renal artery stenosis?
What is the efficacy of Vygart (Vigabatrin) compared to alternative medications for the treatment of myasthenia gravis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.